Resistance to activated protein C in unselected patients with arterial and venous thrombosis

Elena M. Faioni, Cristina Razzari, Ida Martinelli, Daniela Panzeri, Franca Franchi, Pier Mannuccio Mannucci

Research output: Contribution to journalArticle

Abstract

Four hundred and ninety-three consecutive patients referred for arterial or venous thrombosis were screened for congenital and acquired abnormalities of blood coagulation predisposing to thrombosis, end were compared to 341 age- and sex-matched controls. The aim of the study was to determine the prevalence and clinical characteristics of resistance to activated protein C (APC), a defect shown to have different prevalences in different ethnic groups and to be associated with an increased risk of thrombosis. Seventy- three (15%) patients had both APC resistance and the 1691 G to A factor V gone mutation, compared to 6/341 (2%) controls. Seven patients had antithrombin deficiency (1.4%), 11 had protein C deficiency (2.2%), and 4 had protein S deficiency (0.8%). The relative risk of thrombosis in APC-resistant patients was 9.4. Resistance to APC was associated mainly with venous thrombosis, the moat frequent being deep-vein thrombosis of the lower limbs. Fifty-eight percent of APC-resistant patients had an associated risk factor at the first thrombotic event: pregnancy and oral contraceptive intake were associated with the first thrombotic episode in 35% and 30% of women, respectively. APC resistance is the most frequent defect of blood coagulation in the general population and in the unselected thrombotic population studied by us.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalAmerican Journal of Hematology
Volume55
Issue number2
DOIs
Publication statusPublished - Jun 1997

Fingerprint

Activated Protein C Resistance
Venous Thrombosis
Thrombosis
Blood Coagulation
Protein C
Protein S Deficiency
Protein C Deficiency
Factor V
Antithrombins
Oral Contraceptives
Ethnic Groups
Population
Lower Extremity
Pregnancy
Mutation

Keywords

  • Antithrombin
  • APC resistance
  • Protein C
  • Protein S
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Resistance to activated protein C in unselected patients with arterial and venous thrombosis. / Faioni, Elena M.; Razzari, Cristina; Martinelli, Ida; Panzeri, Daniela; Franchi, Franca; Mannucci, Pier Mannuccio.

In: American Journal of Hematology, Vol. 55, No. 2, 06.1997, p. 59-64.

Research output: Contribution to journalArticle

Faioni, Elena M. ; Razzari, Cristina ; Martinelli, Ida ; Panzeri, Daniela ; Franchi, Franca ; Mannucci, Pier Mannuccio. / Resistance to activated protein C in unselected patients with arterial and venous thrombosis. In: American Journal of Hematology. 1997 ; Vol. 55, No. 2. pp. 59-64.
@article{7771f93f6d5f40ae8a352e6626c79b8f,
title = "Resistance to activated protein C in unselected patients with arterial and venous thrombosis",
abstract = "Four hundred and ninety-three consecutive patients referred for arterial or venous thrombosis were screened for congenital and acquired abnormalities of blood coagulation predisposing to thrombosis, end were compared to 341 age- and sex-matched controls. The aim of the study was to determine the prevalence and clinical characteristics of resistance to activated protein C (APC), a defect shown to have different prevalences in different ethnic groups and to be associated with an increased risk of thrombosis. Seventy- three (15{\%}) patients had both APC resistance and the 1691 G to A factor V gone mutation, compared to 6/341 (2{\%}) controls. Seven patients had antithrombin deficiency (1.4{\%}), 11 had protein C deficiency (2.2{\%}), and 4 had protein S deficiency (0.8{\%}). The relative risk of thrombosis in APC-resistant patients was 9.4. Resistance to APC was associated mainly with venous thrombosis, the moat frequent being deep-vein thrombosis of the lower limbs. Fifty-eight percent of APC-resistant patients had an associated risk factor at the first thrombotic event: pregnancy and oral contraceptive intake were associated with the first thrombotic episode in 35{\%} and 30{\%} of women, respectively. APC resistance is the most frequent defect of blood coagulation in the general population and in the unselected thrombotic population studied by us.",
keywords = "Antithrombin, APC resistance, Protein C, Protein S, Thrombosis",
author = "Faioni, {Elena M.} and Cristina Razzari and Ida Martinelli and Daniela Panzeri and Franca Franchi and Mannucci, {Pier Mannuccio}",
year = "1997",
month = "6",
doi = "10.1002/(SICI)1096-8652(199706)55:2<59::AID-AJH2>3.0.CO;2-1",
language = "English",
volume = "55",
pages = "59--64",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Resistance to activated protein C in unselected patients with arterial and venous thrombosis

AU - Faioni, Elena M.

AU - Razzari, Cristina

AU - Martinelli, Ida

AU - Panzeri, Daniela

AU - Franchi, Franca

AU - Mannucci, Pier Mannuccio

PY - 1997/6

Y1 - 1997/6

N2 - Four hundred and ninety-three consecutive patients referred for arterial or venous thrombosis were screened for congenital and acquired abnormalities of blood coagulation predisposing to thrombosis, end were compared to 341 age- and sex-matched controls. The aim of the study was to determine the prevalence and clinical characteristics of resistance to activated protein C (APC), a defect shown to have different prevalences in different ethnic groups and to be associated with an increased risk of thrombosis. Seventy- three (15%) patients had both APC resistance and the 1691 G to A factor V gone mutation, compared to 6/341 (2%) controls. Seven patients had antithrombin deficiency (1.4%), 11 had protein C deficiency (2.2%), and 4 had protein S deficiency (0.8%). The relative risk of thrombosis in APC-resistant patients was 9.4. Resistance to APC was associated mainly with venous thrombosis, the moat frequent being deep-vein thrombosis of the lower limbs. Fifty-eight percent of APC-resistant patients had an associated risk factor at the first thrombotic event: pregnancy and oral contraceptive intake were associated with the first thrombotic episode in 35% and 30% of women, respectively. APC resistance is the most frequent defect of blood coagulation in the general population and in the unselected thrombotic population studied by us.

AB - Four hundred and ninety-three consecutive patients referred for arterial or venous thrombosis were screened for congenital and acquired abnormalities of blood coagulation predisposing to thrombosis, end were compared to 341 age- and sex-matched controls. The aim of the study was to determine the prevalence and clinical characteristics of resistance to activated protein C (APC), a defect shown to have different prevalences in different ethnic groups and to be associated with an increased risk of thrombosis. Seventy- three (15%) patients had both APC resistance and the 1691 G to A factor V gone mutation, compared to 6/341 (2%) controls. Seven patients had antithrombin deficiency (1.4%), 11 had protein C deficiency (2.2%), and 4 had protein S deficiency (0.8%). The relative risk of thrombosis in APC-resistant patients was 9.4. Resistance to APC was associated mainly with venous thrombosis, the moat frequent being deep-vein thrombosis of the lower limbs. Fifty-eight percent of APC-resistant patients had an associated risk factor at the first thrombotic event: pregnancy and oral contraceptive intake were associated with the first thrombotic episode in 35% and 30% of women, respectively. APC resistance is the most frequent defect of blood coagulation in the general population and in the unselected thrombotic population studied by us.

KW - Antithrombin

KW - APC resistance

KW - Protein C

KW - Protein S

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0030746710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030746710&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8652(199706)55:2<59::AID-AJH2>3.0.CO;2-1

DO - 10.1002/(SICI)1096-8652(199706)55:2<59::AID-AJH2>3.0.CO;2-1

M3 - Article

C2 - 9208999

AN - SCOPUS:0030746710

VL - 55

SP - 59

EP - 64

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -